Bikash Debnath

3.3k total citations · 2 hit papers
69 papers, 2.5k citations indexed

About

Bikash Debnath is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Bikash Debnath has authored 69 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Infectious Diseases. Recurrent topics in Bikash Debnath's work include Computational Drug Discovery Methods (10 papers), HIV/AIDS drug development and treatment (10 papers) and Biochemical and Molecular Research (7 papers). Bikash Debnath is often cited by papers focused on Computational Drug Discovery Methods (10 papers), HIV/AIDS drug development and treatment (10 papers) and Biochemical and Molecular Research (7 papers). Bikash Debnath collaborates with scholars based in India, United States and China. Bikash Debnath's co-authors include Nouri Neamati, Helen Ha, Shili Xu, Nouri Neamati, Kuntal Manna, Tarun Jha, Soma Samanta, Waikhom Somraj Singh, Antonio Garofalo and Fedora Grande and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Bikash Debnath

65 papers receiving 2.5k citations

Hit Papers

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory... 2017 2026 2020 2023 2017 2018 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bikash Debnath India 24 948 657 498 422 239 69 2.5k
Guangli Yang China 30 1.5k 1.5× 907 1.4× 742 1.5× 570 1.4× 70 0.3× 76 3.5k
Tinghong Ye China 38 1.9k 2.0× 683 1.0× 468 0.9× 376 0.9× 88 0.4× 126 4.1k
Sushil Kumar India 22 1.8k 1.9× 793 1.2× 334 0.7× 293 0.7× 149 0.6× 67 3.4k
Xing Du China 22 1.5k 1.6× 278 0.4× 166 0.3× 193 0.5× 301 1.3× 47 2.7k
Giorgio Cozza Italy 32 2.9k 3.0× 559 0.9× 255 0.5× 691 1.6× 602 2.5× 88 4.6k
Renata Kontek Poland 23 1.4k 1.5× 723 1.1× 199 0.4× 439 1.0× 94 0.4× 74 3.3k
Zhuorong Li China 33 1.9k 2.0× 362 0.6× 218 0.4× 862 2.0× 154 0.6× 171 4.4k
Vanicha Vichai Thailand 13 1.6k 1.7× 516 0.8× 151 0.3× 696 1.6× 91 0.4× 30 3.4k
Yiqing Zhou China 26 866 0.9× 202 0.3× 356 0.7× 141 0.3× 71 0.3× 91 2.3k

Countries citing papers authored by Bikash Debnath

Since Specialization
Citations

This map shows the geographic impact of Bikash Debnath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bikash Debnath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bikash Debnath more than expected).

Fields of papers citing papers by Bikash Debnath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bikash Debnath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bikash Debnath. The network helps show where Bikash Debnath may publish in the future.

Co-authorship network of co-authors of Bikash Debnath

This figure shows the co-authorship network connecting the top 25 collaborators of Bikash Debnath. A scholar is included among the top collaborators of Bikash Debnath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bikash Debnath. Bikash Debnath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Saha, Sourav, et al.. (2024). Recent Advances in Multifaceted Drug Delivery Using Natural Polysaccharides and Polyacrylamide-based Nanomaterials in Nanoformulation. Current Topics in Medicinal Chemistry. 25(4). 395–408. 1 indexed citations
3.
Manna, Kuntal, et al.. (2023). Metabolites Study of Experimental Plant Derived Alkaloids: A Review. The Natural Products Journal. 13(7). 4 indexed citations
4.
Samanta, Soma, Suhui Yang, Bikash Debnath, et al.. (2021). The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress–Mediated Apoptosis in Pancreatic Cancer. Cancer Research. 81(7). 1883–1895. 78 indexed citations
5.
Debnath, Bikash, Waikhom Somraj Singh, & Kuntal Manna. (2021). A phytopharmacological review on Ananas comosus. Advances in Traditional Medicine. 23(2). 291–298. 14 indexed citations
6.
Debnath, Bikash, Waikhom Somraj Singh, & Kuntal Manna. (2020). The Outbreak of Coronavirus Disease 2019 (COVID-19) and its Manifestation. Coronaviruses. 2(7). 2 indexed citations
7.
Huddle, Brandt C., Edward Grimley, Cameron D. Buchman, et al.. (2020). Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy. European Journal of Medicinal Chemistry. 211. 113060–113060. 13 indexed citations
8.
Debnath, Bikash, Waikhom Somraj Singh, Manik Das, et al.. (2018). Role of plant alkaloids on human health: A review of biological activities. Materials Today Chemistry. 9. 56–72. 261 indexed citations breakdown →
9.
Manna, Kuntal, et al.. (2018). Phytochemical Analysis, Anti-oxidant and Cytotoxic Activity of Seed Coat of Macrotyloma uniflorum in Different Solvents. Natural Products Chemistry & Research. 6(5). 1–7. 2 indexed citations
10.
Debnath, Bikash, et al.. (2016). Discovery of novel 3-hydroxypicolinamides as selective inhibitors of HIV-1 integrase-LEDGF/p75 interaction. European Journal of Medicinal Chemistry. 125. 1051–1063. 9 indexed citations
11.
Debnath, Bikash, et al.. (2015). Nanoparticle (NP) as a Targeting Drug Delivery System to Blood-Brain Barrier (BBB): A Review. Pharmatutor. 3(8). 30–37. 1 indexed citations
12.
Debnath, Bikash, et al.. (2015). ESTIMATION OF ALKALOIDS AND PHENOLICS OF FIVE EDIBLE CUCURBITACEOUS PLANTS AND THEIR ANTIBACTERIAL ACTIVITY. International Journal of Pharmacy and Pharmaceutical Sciences. 7(12). 223–227. 14 indexed citations
13.
Debnath, Bikash, Shili Xu, Fedora Grande, Antonio Garofalo, & Nouri Neamati. (2013). Small Molecule Inhibitors of CXCR4. Theranostics. 3(1). 47–75. 216 indexed citations
14.
Fan, Xing, Li‐Fan Zeng, Bikash Debnath, et al.. (2011). Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: A scaffold hopping approach using salicylate and catechol groups. Bioorganic & Medicinal Chemistry. 19(16). 4935–4952. 38 indexed citations
15.
Debnath, Bikash, Laith Q. Al‐Mawsawi, & Nouri Neamati. (2010). Are we living in the end of the blockbuster drug era?. Drug News & Perspectives. 23(10). 670–670. 19 indexed citations
16.
Samanta, Soma, Bikash Debnath, Anindya Basu, et al.. (2006). Exploring QSAR on 3-aminopyrazoles as antitumor agents for their inhibitory activity of CDK2/cyclin A. European Journal of Medicinal Chemistry. 41(10). 1190–1195. 28 indexed citations
17.
Samanta, Soma, Bikash Debnath, Shovanlal Gayen, et al.. (2005). QSAR modeling on dopamine D2 receptor binding affinity of 6-methoxy benzamides. Il Farmaco. 60(10). 818–825. 18 indexed citations
18.
Debnath, Bikash, Soma Samanta, Sudip Kumar Naskar, Kunal Roy, & Tarun Jha. (2003). QSAR Study on the Affinity of Some Arylpiperazines towards the 5-HT1A/α1-Adrenergic Receptor Using the E-State Index. Bioorganic & Medicinal Chemistry Letters. 13(17). 2837–2842. 23 indexed citations
19.
Debnath, Bikash, et al.. (2002). Enhanced regression of tumors in mice with combined chemotherapy and immunotherapy. Indian Journal of Pharmacology. 34(3). 172–177. 8 indexed citations
20.
Srikanth, Kolluru D., Bikash Debnath, & Tarun Jha. (2002). QSAR study on adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues using the hansch approach. Bioorganic & Medicinal Chemistry Letters. 12(6). 899–902. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026